Analyst Price Targets — ICU
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 14, 2026 1:06 pm | Anthony Vendetti | Maxim Group | $8.00 | $4.49 | TheFly | SeaStar Medical price target raised to $8 from $6 at Maxim |
| February 12, 2026 2:03 pm | — | Maxim Group | $6.00 | $2.30 | TheFly | SeaStar Medical price target lowered to $6 from $10 at Maxim |
Latest News for ICU
Sponsors educational summit of leading pediatric AKI health care experts Announces best practices webinar to further advance new treatment options DENVER, July 14, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life announced today that it is…
Enables standardized inpatient hospital billing for QUELIMMUNE ® (SCD-PED) therapy
DENVER, June 22, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life, announced today that Eric Schlorff, Chief Executive Officer of SeaStar Medical, will present at the Virtual Investor Summit Conference on Wednesday, June 24th at 10:30 am…
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
2,447 shares sold for a transaction value of ~$304,000. This sale represented 11.17% of Sanzone's direct holdings.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ICU.
U.S. House Trading
No House trades found for ICU.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.